Sickle cell crisis: is it analgesia within 15 minutes or 30?
NICE and RCEM give different numbers, and both are current. Here is which applies in an emergency department, and why the conflict exists.
This is a genuine conflict between two live guidelines rather than one of them being out of date, and it is worth understanding rather than memorising a number.
What each one says
| Source | Analgesia within | Reassess |
|---|---|---|
| NICE CG143 (2012) | 30 minutes of presentation (1.1.4) | Every 30 minutes until satisfactory, then at least 4-hourly (1.1.12) |
| RCEM BPG v3.2 (March 2024) | 15 minutes of presentation | Within 15 minutes for severe pain; within 30 for mild to moderate |
The RCEM document is explicit, and it reproduces the NICE figure separately in its own summary as "[NICE guidance]" — so it is not an oversight. RCEM has knowingly tightened the standard.
Which governs in an emergency department
The principle behind the change is the one worth carrying: pain is treated on its severity, not on its cause. There is no clinical reason a sickle crisis should wait twice as long as any other severe pain, and historically patients with sickle cell disease have waited considerably longer than either standard allows.
The rest of the standard
- Assess pain with an age-appropriate scoring tool at presentation.
- Offer a strong opioid to anyone with severe pain, and to anyone with moderate pain who has already taken something before arriving.
- Offer regular paracetamol and, unless contraindicated, an NSAID in addition to the opioid. NSAIDs are avoided in the third trimester.
- Do not offer pethidine (NICE CG143, 1.1.11).
- Refer to the patient's individual care plan where one exists. Patients know their own crises and what works.
If it comes up in an exam
Quote the RCEM standard — 15 minutes, reassessed within 15 for severe pain — and know that NICE CG143 says 30. A question that offers both is testing whether you know which body sets the standard for your department.
Sources
- RCEM Best Practice Guideline: Management of Acute Presentations of Sickle Cell Disease, v3.2 — March 2024
- NICE CG143: Sickle cell disease — managing acute painful episodes in hospital — recommendations 1.1.4 and 1.1.12
- RCEM Best Practice Guideline: Management of Pain in Adults — 2024 — the general standard of analgesia within 15 minutes for moderate or severe pain
This is how the whole bank is written
Every question names the guidance it rests on, every option gets an explanation — including the wrong ones — and anything that has changed recently is checked against the source rather than recalled. Twenty questions free, no card.
Try 20 questionsWritten for doctors preparing for postgraduate examinations. It is a revision aid, not clinical advice, and guidance changes — always work from the current guideline and your local protocols. Resus Review is independent and is not affiliated with or endorsed by the Royal College of Emergency Medicine, NICE, or Resuscitation Council UK.